Q Biomed Inc (QBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 11/30
| 11-2021 | 08-2021 | 05-2021 | 02-2021 | 11-2020 | |
| Sales | 105 | 46 | 45 | 0 | 0 |
| Cost of Goods | 86 | 74 | 46 | 41 | 133 |
| Gross Profit | 19 | -28 | -1 | -41 | -133 |
| Operating Expenses | 1,727 | 1,648 | 1,858 | 2,351 | 3,426 |
| Operating Income | -1,622 | -1,602 | -1,813 | -2,351 | -3,426 |
| Interest Expense | 272 | 99 | 85 | 50 | 5 |
| Other Income | -175 | -86 | -10 | -74 | 0 |
| Pre-tax Income | -2,070 | -1,787 | -1,908 | -2,475 | -3,430 |
| Net Income Continuous | -2,070 | -1,787 | -1,908 | -2,475 | -3,430 |
| Net Income | $-2,070 | $-1,787 | $-1,908 | $-2,475 | $-3,430 |
| EPS Basic Total Ops | -0.07 | -0.07 | -0.08 | -0.11 | -0.14 |
| EPS Basic Continuous Ops | -0.07 | -0.06 | -0.07 | -0.10 | -0.13 |
| EPS Diluted Total Ops | -0.07 | -0.07 | -0.08 | -0.11 | -0.14 |
| EPS Diluted Continuous Ops | -0.07 | -0.06 | -0.07 | -0.10 | -0.13 |
| EPS Diluted Before Non-Recurring Items | -0.08 | -0.07 | -0.08 | N/A | N/A |
| EBITDA(a) | $-1,390 | $-1,511 | $-1,730 | $-2,299 | $-3,411 |